Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FTC Denies Abusing Power In Watson Investigation
Pharmalot
Friday, July 23, 2010 - 6:57am
tags:
FTC, Watson Pharmaceuticals, Provigil, Apotex, generics, Cephalon
Tibotec unveils results of experimental HIV drug
Fierce Biotech
Friday, July 23, 2010 - 6:41am
tags:
Tibotec, HIV, JNJ, rilpivirine
Human Genome Sciences revenue rises
Bizjournals.com
Friday, July 23, 2010 - 6:40am
tags:
earnings, Human Genome Sciences
The Value of an SPA for Avanir Pharmaceuticals
Seeking Alpha
Friday, July 23, 2010 - 6:38am
tags:
Vivus, SPA, Avanir
Reports of Psychotic Violence on Anti-Smoking Drug Chantix Pile Up But Pfizer Isn't Seeing Them
BNET Pharma
Friday, July 23, 2010 - 6:36am
tags:
smoking cessation, Pfizer, Chantix
Why I Bought Call Options on Mylan
Seeking Alpha
Friday, July 23, 2010 - 6:34am
tags:
Mylan, Eli Lilly, JNJ, Bristol-Myers Squibb, Teva Pharmaceuticals, generics
Elan's Loss Widens After Setting Aside $206 Million in U.S. for Zonegran
Bloomberg
Thursday, July 22, 2010 - 5:30pm
tags:
Elan, earnings
Drugmaker Actavis agrees debt refinancing deal
Reuters
Thursday, July 22, 2010 - 5:29pm
tags:
Actavis, debt refinancing
Repros begins Proellex study, shares spike
Bizjournals.com
Thursday, July 22, 2010 - 5:27pm
tags:
Proellex, Repros Therapeutics, endometriosis, uterine fibroids, fibroids
How Brand-Name Drugmakers Fight Generics
Pharmalot
Thursday, July 22, 2010 - 3:54pm
tags:
generics
A Sign of More Good Things to Come for Abbott
Motley Fool
Thursday, July 22, 2010 - 3:52pm
tags:
Abbott Laboratories
AstraZeneca Said to Pay $2 Million in Seroquel Cases
Bloomberg Businessweek
Thursday, July 22, 2010 - 3:51pm
tags:
settlements, AstraZeneca, antipsychotics, Seroquel
It's All About the Future for Amylin
Motley Fool
Thursday, July 22, 2010 - 3:49pm
tags:
Amylin, Bydureon, Byetta, diabetes, Novo Nordisk, Victoza, Merck, Januvia, Takeda, Actos, Onglyza, AstraZeneca
FDA asks NicOx for new naproxcinod trial
Fierce Biotech
Thursday, July 22, 2010 - 10:01am
tags:
FDA, NicOx, naproxcinod, osteoarthritis
What Investors Think About NeurogesX
Motley Fool
Thursday, July 22, 2010 - 9:59am
tags:
investors, NeurogesX
Avi BioPharma shares up on $291 mln U.S. accord
Marketwatch
Thursday, July 22, 2010 - 9:52am
tags:
AVI BioPharma, federal contracts
What Investors Think About Lannett
Motley Fool
Thursday, July 22, 2010 - 9:51am
tags:
Lannett, investors
FDA “must publish all safety, efficacy data from drug apps”
Pharma Times, UK
Thursday, July 22, 2010 - 9:45am
tags:
FDA, drug safety
Lawyers for about 5,200 current and former Sanofi-Aventis female sales reps ask for $15.36 million settlement in sex-bias case
Reuters
Thursday, July 22, 2010 - 9:40am
tags:
Sanofi, discrimination, settlements
Decision Resources: Only half of payers support biosimilar substitution
Drugstore News
Thursday, July 22, 2010 - 9:35am
tags:
biosimilars

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.